The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Moy-Fincher Medical Group.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Moy-Fincher Medical Group
ClinicalTrials.gov Identifier:
NCT00969475
First received: August 29, 2009
Last updated: September 13, 2009
Last verified: September 2009
  Purpose

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.


Condition Intervention
Scars
Device: Lumenis fractional carbon dioxide laser

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effects of Fractional CO2 Resurfacing Prior to Complex Wound Closure

Resource links provided by NLM:


Further study details as provided by Moy-Fincher Medical Group:

Primary Outcome Measures:
  • Evidence of scar improvement as assessed by blinded-observer and patient ratings. [ Time Frame: At two and six weeks following the procedure ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: October 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Half of each subject's wound will not be treated.
Experimental: Laser resurfacing
Half of each subject's wound will be treated with a fractional CO2 laser.
Device: Lumenis fractional carbon dioxide laser
intra-operative laser resurfacing at time of wound closure
Other Name: Lumenis

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Undergoing skin cancer surgery
  • Will have a straight-line incision
  • Fluent in English
  • Must reside in the Los Angeles vicinity for the duration of the study

Exclusion Criteria:

  • Non-English speakers
  • Pregnant or cognitively impaired subjects
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00969475

Contacts
Contact: Telia DeBoyes tdeboyes@yahoo.com

Locations
United States, California
Moy-Fincher Medical Group Not yet recruiting
Los Angeles, California, United States, 90095
Contact    310-794-7422      
Principal Investigator: David Ozog, MD         
Sub-Investigator: Edgar Fincher, MD         
Sub-Investigator: Ronald Moy, MD         
Sub-Investigator: Lisa Chipps, MD         
Sponsors and Collaborators
Moy-Fincher Medical Group
Investigators
Principal Investigator: David Ozog, MD Moy-Fincher Medical Group
  More Information

No publications provided

Responsible Party: Ronald Moy, MD, Moy-Fincher Medical Group
ClinicalTrials.gov Identifier: NCT00969475     History of Changes
Other Study ID Numbers: MF-01
Study First Received: August 29, 2009
Last Updated: September 13, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Moy-Fincher Medical Group:
scar revision
intraoperative
fractional carbon dioxide laser

ClinicalTrials.gov processed this record on October 01, 2014